125 related articles for article (PubMed ID: 3049565)
21. Phenotypic characterization of human T lymphocyte populations producing macrophage-activating factor (MAF) lymphokines.
Biondi A; Roach JA; Schlossman SF; Todd RF
J Immunol; 1984 Jul; 133(1):281-5. PubMed ID: 6373929
[TBL] [Abstract][Full Text] [Related]
22. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma.
Ratliff TL; Thomasson DL; McCool RE; Catalona WJ
J Reticuloendothel Soc; 1982 May; 31(5):393-7. PubMed ID: 6181257
[TBL] [Abstract][Full Text] [Related]
23. Biological and biochemical characterization of macrophage activating factor (MAF) in murine lymphocytes: physiocochemical similarity of MAF to gamma interferon (IFN-gamma).
Fukazawa Y; Kagaya K; Miura H; Shinoda T; Natori K; Yamazaki S
Microbiol Immunol; 1984; 28(6):691-702. PubMed ID: 6434908
[TBL] [Abstract][Full Text] [Related]
24. Constitutive production of a non-interferon macrophage activating factor by HTLV-transformed T cells.
Lee JC
Lymphokine Res; 1986; 5 Suppl 1():S127-32. PubMed ID: 3023762
[TBL] [Abstract][Full Text] [Related]
25. Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma.
Margolick JB; Ambrus JL; Volkman DJ; Fauci AS
J Immunol; 1986 Jan; 136(2):546-54. PubMed ID: 2416812
[TBL] [Abstract][Full Text] [Related]
26. Lymphokine stimulation of human macrophage C2 production is partially due to interferon-gamma.
Sanders KM; Littman BH
J Immunol; 1986 Aug; 137(3):876-9. PubMed ID: 3088114
[TBL] [Abstract][Full Text] [Related]
27. Biological and antigenic similarities of murine interferon-gamma and macrophage-activating factor.
Svedersky LP; Benton CV; Berger WH; Rinderknecht E; Harkins RN; Palladino MA
J Exp Med; 1984 Mar; 159(3):812-27. PubMed ID: 6421982
[TBL] [Abstract][Full Text] [Related]
28. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis.
Liew FY; Millott S; Li Y; Lelchuk R; Chan WL; Ziltener H
Eur J Immunol; 1989 Jul; 19(7):1227-32. PubMed ID: 2503386
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of a non-interferon antileishmanial macrophage activating factor (antileishmanial MAF).
Van Niel A; Zacks SE; David JR; Remold HG; Weiser WY
Adv Exp Med Biol; 1988; 239():231-7. PubMed ID: 3059767
[TBL] [Abstract][Full Text] [Related]
30. Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon.
Schreiber RD; Pace JL; Russell SW; Altman A; Katz DH
J Immunol; 1983 Aug; 131(2):826-32. PubMed ID: 6408190
[TBL] [Abstract][Full Text] [Related]
31. Cellular defenses against Toxoplasma gondii in newborns.
Wilson CB; Haas JE
J Clin Invest; 1984 Jun; 73(6):1606-16. PubMed ID: 6327765
[TBL] [Abstract][Full Text] [Related]
32. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
Kleinerman ES; Ceccorulli LM; Bonvini E; Zicht R; Gallin JI
Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242
[TBL] [Abstract][Full Text] [Related]
33. Identification of a T cell hybridoma that produces large quantities of macrophage-activating factor.
Schreiber RD; Altman A; Katz DH
J Exp Med; 1982 Sep; 156(3):677-89. PubMed ID: 7050288
[TBL] [Abstract][Full Text] [Related]
34. Secretion of a macrophage-activating factor distinct from interferon-gamma by human T cell clones.
Andrew PW; Rees AD; Scoging A; Dobson N; Matthews R; Whittall JT; Coates AR; Lowrie DB
Eur J Immunol; 1984 Oct; 14(10):962-4. PubMed ID: 6436035
[TBL] [Abstract][Full Text] [Related]
35. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
Hamann U; Krammer PH
Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
[TBL] [Abstract][Full Text] [Related]
36. Macrophage activation factor from EL-4, a murine T-cell line: antigenic characterization by hamster monoclonal antibodies to murine interferon-gamma.
Meltzer MS; Gilbreath MJ; Crawford RM; Schreiber RD; Nacy CA
Cell Immunol; 1987 Jul; 107(2):340-7. PubMed ID: 3109744
[TBL] [Abstract][Full Text] [Related]
37. Human non-interferon macrophage activating factor: biological and biochemical characterization.
Lee JC; Badger AM; Johnson WJ
Adv Exp Med Biol; 1988; 239():217-21. PubMed ID: 3264453
[TBL] [Abstract][Full Text] [Related]
38. An assay for macrophage activating factor based on the adherence of oil-elicited guinea pig macrophages: characterization of a lymphokine-induced release of hydrogen peroxide from elicited macrophages.
Talmadge KW; Peck R
Lymphokine Res; 1986; 5(1):35-47. PubMed ID: 3511329
[TBL] [Abstract][Full Text] [Related]
39. Studies on the mechanism of liver injury by macrophage-mediated cytotoxicity--partial purification of cytotoxic factor detected in the culture supernatant of activated macrophages.
Mizoguchi Y; Tsutsui H; Monna T; Yamamoto S; Morisawa S
Gastroenterol Jpn; 1983 Feb; 18(1):41-6. PubMed ID: 6339309
[TBL] [Abstract][Full Text] [Related]
40. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
Murray HW; Spitalny GL; Nathan CF
J Immunol; 1985 Mar; 134(3):1619-22. PubMed ID: 3918107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]